+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colorectal Cancer Screening and Diagnostics Market

  • PDF Icon

    Report

  • 166 Pages
  • February 2025
  • Region: Global
  • BCC Research
  • ID: 6054969
Description Jump to:
The Colorectal Cancer Screening and Diagnostics Market was valued at USD 40 Billion in 2024, and is projected to reach USD 46.1 Billion by 2029, rising at a CAGR of 2.90%.

The increasing incidence of colorectal cancer, rise in demand for non-invasive colorectal cancer screening, growing need for early cancer detection to lower treatment cost, advances in genomics and molecular diagnostics, and rising financial burden on healthcare are key factors driving the market’s growth. However, the limited sensitivity of non-invasive testing methods, sample collection challenges, and stringent regulations might hinder the market’s growth in the next five years.

This report segments the global market by test type, end user, and region. By test type, the colonoscopy and sigmoidoscopy segment held the largest market share in 2023, and this segment is expected to grow at a CAGR of 1.7% during the forecast period.

In terms of end users, the hospital and clinic segment is forecast to grow at a CAGR of 2.6% during the forecast period. This segment dominated with 69.3% of the market in 2023 and is forecast to reach a value of $31.4 billion by the end of 2029.

North America held the largest regional market share, with 60.8% in 2023. An increasing number of screening tests for colorectal cancer coupled with the significant regional presence of key product manufacturers are responsible for a large share.

Leading product manufacturers in the global market include Fujifilm Holdings Corp., Olympus Corp., Exact Sciences Corp., Danaher Corp., Guardant Health, and New Horizon Health.

Report Scope

This report summarizes the colorectal cancer screening and diagnostic testing service market, including a market snapshot and company profiles of leading product manufacturers/service providers. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges, and opportunities. It provides information on emerging technologies and developments in the industry. The report also analyzes critical market players' financials, product portfolios, and recent activities.

The publisher analyzed and made projections of each market and its applications, along with forecasts for the next five years. The report also features profiles of leading product manufacturers/service providers in the colorectal cancer screening and diagnostic testing service industry, including Fujifilm Holdings Corporation, Olympus Corporation, Exact Sciences Corporation, Danaher Corporation, Guardant Health, New Horizon Health, and Quest Diagnostics.

The market is segmented by geographical region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

Regional analysis is further segregated:

  • North America: The U.S., Canada, and Mexico
  • Europe: Germany, the U.K., France, Italy, Spain, and the Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific
Data for market estimates have been provided for 2021 and 2022 as the historical years and 2023 as the base year, with the forecast through 2029.

The report includes:

  • 37 data tables and 71 additional tables
  • Analyses of trends in the global market for colorectal cancer screening and diagnostics, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Estimates and forecasts of the market size by type, end user and geographic region
  • Discussion of emerging technologies and developments, and the macroeconomic factors affecting the market
  • Coverage of stages, etiology, pathophysiology, and risk factors of colorectal cancer, and discussion on its diagnosis, regulatory framework and reimbursement scenarios
  • Information on product pipeline, approvals, launches and expansions and funding and grants in the medical industry
  • Review of patent data and other new developments
  • Discussion of ESG challenges and practices of the industry
  • Assessment of the competitive landscape, including the market shares of leading companies, their product portfolios and financial overviews
  • Information on recent mergers and acquisitions, expansions, collaborations, investments, and divestments
  • Company profiles of major players within the industry, including Fujifilm Holdings Corp., Olympus Corp., Exact Sciences Corp., Danaher Corp., and Guardant Health

Table of Contents

Chapter 1 Executive Summary
  • Market Outlook
  • Scope of Report
  • Market Insights
Chapter 2 Market Overview
  • Disease Area Overview
  • Stages of Colorectal Cancer
  • Stage 0
  • Stage I
  • Stage II
  • Stage III
  • Stage IV
  • Etiology
  • Genetic Factors
  • Environmental Factors
  • Pathophysiology
  • Germline Mutations
  • Sporadic Mutations
  • Metastasis
  • Clinical Implications
  • Risk Factors
  • Inherited Syndromes
  • Lynch Syndrome (HNPCC)
  • Familial Adenomatous Polyposis (FAP)
  • Diagnosis
  • Prognosis
  • Types of Colorectal Cancer
  • Colorectal Adenocarcinoma
  • Gastrointestinal Stromal Tumors (GISTs)
  • Carcinoids
  • Turcot Syndrome
  • Peutz-Jeghers Syndrome (PJS)
  • Familial Colorectal Cancer (FCC)
  • Juvenile Polyposis Syndrome (JPS)
  • Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)
  • MUTYH-Associated Polyposis (MAP)
  • Market Definition
  • Inclusion and Exclusion Criteria
  • Inclusion Criteria
  • Exclusion Criteria
  • Market Introduction
  • The Road Ahead
  • Global Prevalence of Colorectal Cancer
  • Industry Outlook: Regulatory Framework
  • Regulatory Framework in the U.S.
  • Regulatory Framework in Europe
  • Regulatory Framework in the Asia-Pacific Region
  • Regulatory Landscape in Latin America
  • Reimbursement Scenarios
  • Colonoscopy and Sigmoidoscopy Tests
  • Stool DNA Test
  • Fecal Immunochemical Tests (FIT)
  • Fecal Occult Blood Tests (FOBT)
  • Blood-based/Biomarker Tests
  • Product Pipeline
  • Comparison of Colorectal Cancer Screening and Diagnostic Tests
  • Colonoscopy Tests
  • Sigmoidoscopy Tests
  • Fecal Immunochemical Tests (FIT)
  • Guaiac Fecal Occult Blood Tests (gFOBT)
  • Stool DNA Tests
Chapter 3 Market Dynamics
  • Market Dynamics Snapshot
  • Market Drivers
  • Increasing Incidence of Colorectal Cancer
  • Growing Financial Burden
  • Advances in Genomics and Molecular Diagnostics
  • Rise in Demand for Non-Invasive Colorectal Cancer Screening
  • Growing Need for Early Cancer Detection to Lower Treatment Costs
  • Market Restraints
  • Limited Sensitivity of Non-Invasive Testing Methods
  • Sample Collection Challenges
  • Stringent Regulations
  • Market Opportunities
  • Global Expansion of Colorectal Cancer Screening Programs
  • Emerging Economies Proposing Significant Untapped Potential
Chapter 4 Emerging Technologies and Developments
  • Introduction
  • Multimodal Approaches to Colorectal Cancer Screening
  • Development of At-Home Colorectal Cancer Screening Kits
  • Emerging Use of Gut Microbiota in Colorectal Cancer Diagnosis
  • Adoption of Artificial Intelligence (AI)
  • Digital Health Interventions
  • Multicancer Detection (MCD) Assays
  • Development of Self-Propelled Colonoscopes
  • Aer-O-Scope Colonoscope
  • ColonoSight
Chapter 5 Market Segmentation Analysis
  • Key Market Trends
  • Segmentation Breakdown
  • Global Market for Colorectal Cancer Screening and Diagnostic Testing Services
  • Market Analysis by Test Type
  • Colonoscopy and Sigmoidoscopy Tests
  • Stool DNA Tests
  • Market Size and Forecast
  • Blood-Based/Biomarker Tests
  • Fecal Occult Blood Tests (FOBT)
  • Fecal Immunochemical Tests (FIT)
  • Market Analysis by End User
  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Ambulatory Centers
  • At-home Care
  • Geographic Breakdown
  • Market Analysis by Region
  • North America
  • Europe
  • Asia-Pacific Region
  • Rest of the World
Chapter 6 Competitive Intelligence
  • Competitive Landscape
  • Partnerships and Collaborations
  • Acquisitions
  • Business Expansions
  • Funding and Grants
  • Product Approvals, Launches and Expansions
  • Regulatory and Legal Activities
  • Medicare and Insurance Coverage
Chapter 7 Sustainability in the Colorectal Cancer Screening and Diagnostic Testing Service Market
  • Introduction
  • Sustainability
  • Concluding Remarks
Chapter 8 Appendix
  • Methodology
  • Sources
  • Abbreviations
  • Company Profiles
  • DANAHER CORP.
  • DIACARTA
  • EIKEN CHEMICAL CO. LTD.
  • EXACT SCIENCES CORP.
  • FREENOME HOLDINGS INC.
  • FUJIFILM HOLDINGS CORP.
  • GI-VIEW
  • GUARDANT HEALTH
  • HANGZHOU NOVAHEALTH TECHNOLOGY CO. LTD.
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
  • LEPU MEDICAL TECHNOLOGY (BEIJING) CO. LTD.
  • MAINZ BIOMED N.V.
  • NOVIGENIX SA
  • OLYMPUS CORP.
  • QUEST DIAGNOSTICS INC.
  • QUIDELORTHO CORP.
List of Tables
Summary Table Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 1 Stage II Substages of Colorectal Cancer
Table 2 Stage III Substages of Colorectal Cancer
Table 3 Stage IV Substages of Colorectal Cancer
Table 4 Regulatory Landscape for Different Parameters for Key Countries
Table 5 Colonoscopy and Sigmoidoscopy Test Reimbursements, by Country, 2024
Table 6 Stool DNA Test Reimbursements, by Country, 2024
Table 7 Fecal Immunochemical Test Reimbursements, by Country, 2024
Table 8 Fecal Occult Blood Test Reimbursements, by Country, 2024
Table 9 Blood-based/Biomarker Test Reimbursements, by Country, 2024
Table 10 Cancer Screening and Diagnostic Product Pipeline, 2024
Table 11 Characteristics of CRC Screening Tests Currently Available in the U.S., 2024
Table 12 Characteristics of Recommended Colorectal Cancer Screening Tests, 2024
Table 13 Countries with Highest Colorectal Cancer Incidence and Rates, 2022
Table 14 Successful Colorectal Cancer Screening Initiatives, 2004-2011
Table 15 Examples of Product Launches and Approval in the Asia-Pacific Region, 2022
Table 16 Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, Through 2029
Table 17 Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 18 Global Market for Colonoscopy and Sigmoidoscopy Tests, by Region, Through 2029
Table 19 Global Market for Stool DNA Tests, by Region, Through 2029
Table 20 Global Market for Blood-Based/Biomarker Tests, by Region, Through 2029
Table 21 Global Market for Fecal Occult Blood Tests (FOBT), by Region, Through 2029
Table 22 Global Market for Fecal Immunochemical Tests (FIT), by Region, Through 2029
Table 23 Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 24 Global Market for Hospitals and Clinics in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 25 Global Market for Diagnostic Laboratories in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 26 Global Market for Ambulatory Centers in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 27 Global Market for At-home Care in Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 28 Global Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Region, Through 2029
Table 29 North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029
Table 30 North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 31 North American Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 32 European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029
Table 33 European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 34 European Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 35 Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Country, Through 2029
Table 36 Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 37 Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 38 ROW Market for Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, Through 2029
Table 39 ROW Market for Colorectal Cancer Screening and Diagnostic Testing Services, by End User, Through 2029
Table 40 Top Products and Their Manufacturers in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2023
Table 41 Select Strategic Alliances in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 42 Select Acquisitions in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 43 Major Business Expansion Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 44 Major Grants and Funding Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 45 Major Product Approvals, Launches, and Expansions in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 46 Major Regulatory and Legal Activities in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2024
Table 47 Major Medicare and Insurance Coverage in the Colorectal Cancer Screening and Diagnostic Testing Service Market, 2022-2024
Table 48 Recent ESG Highlights from Select Testing Services Providing Companies
Table 49 ESG Rankings for a Few Service-Providing Companies, 2024
Table 50 ESG Rankings for Major Product Manufacturing Companies, 2024
Table 51 Information Sources for this Report
Table 52 Glossary of Terms Used in the Colorectal Cancer Screening and Diagnostic Testing Service Market
Table 53 Danaher Corp.: Company Snapshot
Table 54 Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 55 Danaher Corp.: Product Portfolio
Table 56 Danaher Corp.: News/Key Developments, 2022
Table 57 DiaCarta: Company Snapshot
Table 58 DiaCarta: Product Portfolio
Table 59 DiaCarta: News/Key Developments, 2023
Table 60 Eiken Chemical Co. Ltd.: Company Snapshot
Table 61 Eiken Chemical Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 62 Eiken Chemical Co. Ltd.: Product Portfolio
Table 63 Eiken Chemical Co. Ltd.: News/Key Developments, 2022
Table 64 Exact Sciences Corp.: Company Snapshot
Table 65 Exact Sciences Corp.: Financial Performance, FY 2022 and 2023
Table 66 Exact Sciences Corp.: Product Portfolio
Table 67 Exact Sciences Corp.: News/Key Developments, 2022-2024
Table 68 Freenome Holdings Inc.: Company Snapshot
Table 69 Freenome Holdings Inc.: News/ Key Developments, 2023 and 2024
Table 70 Fujifilm Holdings Corp.: Company Snapshot
Table 71 Fujifilm Holdings Corp.: Financial Performance, FY 2022 and 2023
Table 72 Fujifilm Holdings Corp.: Product Portfolio
Table 73 GI-View: Company Snapshot
Table 74 GI-View: Product Portfolio
Table 75 Guardant Health: Company Snapshot
Table 76 Guardant Health: Financial Performance, FY 2022 and 2023
Table 77 Guardant Health: Product Portfolio
Table 78 Guardant Health: News/Key Developments, 2024
Table 79 Hangzhou NovaHealth Technology Co. Ltd.: Company Snapshot
Table 80 Hangzhou NovaHealth Technology Co. Ltd.: Financial Performance, FY 2021 and 2022
Table 81 Hangzhou NovaHealth Technology Co. Ltd.: Product Portfolio
Table 82 Hangzhou NovaHealth Technology Co. Ltd.: News/Key Developments, 2022
Table 83 Laboratory Corporation of America Holdings: Company Snapshot
Table 84 Laboratory Corporation of America Holdings: Financial Performance, FY 2022 and 2023
Table 85 Laboratory Corporation of America Holdings: Product Portfolio
Table 86 Laboratory Corporation of America Holdings: News/Key Developments, 2024
Table 87 Lepu Medical Technology (Beijing) Co. Ltd.: Company Snapshot
Table 88 Lepu Medical Technology (Beijing) Co. Ltd.: Financial Performance, FY 2022 and 2023
Table 89 Lepu Medical Technology (Beijing) Co. Ltd.: Product Portfolio
Table 90 Mainz Biomed N.V.: Company Snapshot
Table 91 Mainz Biomed N.V.: Financial Performance, FY 2022 and 2023
Table 92 Mainz Biomed N.V.: Product Portfolio
Table 93 Mainz Biomed N.V.: News/Key Developments, 2023 and 2024
Table 94 Novigenix SA: Company Snapshot
Table 95 Novigenix SA: Product Portfolio
Table 96 Olympus Corp.: Company Snapshot
Table 97 Olympus Corp.: Financial Performance, FY 2022 and 2023
Table 98 Olympus Corp.: Product Portfolio
Table 99 Olympus Corp.: News/Key Developments, 2024
Table 100 Quest Diagnostics Inc.: Company Snapshot
Table 101 Quest Diagnostics Inc.: Financial Performance, FY 2022 and 2023
Table 102 Quest Diagnostics Inc.: Product Portfolio
Table 103 Quest Diagnostics Inc.: News/Key Developments, 2023
Table 104 QuidelOrtho Corp.: Company Snapshot
Table 105 QuidelOrtho Corp.: Financial Performance, FY 2022 and 2023
Table 106 QuidelOrtho Corp.: Product Portfolio
Table 107 QuidelOrtho Corp.: News/Key Developments, 2024
List of Figures
Summary Figure Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
Figure 1 Five-Year Survival Rates, by Colorectal Cancer Location
Figure 2 Market Dynamics of Colorectal Cancer Screening and Diagnostic Testing
Figure 3 Emerging Technologies in the Colorectal Cancer Screening and Diagnostic Testing Service Market
Figure 4 Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Test Type, 2023
Figure 5 Global Market for Colonoscopy and Sigmoidoscopy Tests, by Region, 2021-2029
Figure 6 Global Market for Stool DNA Tests, by Region, 2021-2029
Figure 7 Global Market for Blood Based/Biomarker Tests, by Region, 2021-2029
Figure 8 Global Market for Fecal Occult Blood Tests (FOBT), by Region, 2021-2029
Figure 9 Global Market for Fecal Immunochemical Tests (FIT), by Region, 2021-2029
Figure 10 Global Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Region, 2023
Figure 11 North American Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023
Figure 12 U.S. Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 13 Canadian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 14 Mexican Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 15 European Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023
Figure 16 German Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 17 U.K. Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 18 French Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 19 Italian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 20 Spanish Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 21 Rest of European Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 22 Asia-Pacific Market Shares of Colorectal Cancer Screening and Diagnostic Testing Services, by Country, 2023
Figure 23 Chinese Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 24 Japanese Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 25 Indian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 26 South Korean Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 27 Australian Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 28 Rest of Asia-Pacific Market for Colorectal Cancer Screening and Diagnostic Testing Services, 2021-2029
Figure 29 Total Number of Key Developments and Strategies, January 2022-November 2024
Figure 30 Partnerships and Collaborations, January 2022-November 2024
Figure 31 Acquisitions, January 2022-November 2024
Figure 32 Business Expansions, January 2022-November 2024
Figure 33 Funding and Grants, January 2022-November 2024
Figure 34 Product Approvals, Launches and Expansions, January 2022-November 2024
Figure 35 Regulatory and Legal Activities, January 2022-November 2024
Figure 36 Medicare and Insurance Coverage, January 2022-November 2024
Figure 37 Snapshot of ESG Pillars
Figure 38 Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 39 Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 40 Eiken Chemical Co. Ltd.: Revenue Shares, by Product Type, FY 2023
Figure 41 Exact Sciences Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 42 Exact Sciences Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 43 Fujifilm Holdings Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 44 Fujifilm Holdings Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 45 Guardant Health: Revenue Shares, by Business Unit, FY 2023
Figure 46 Guardant Health: Revenue Shares, by Country/Region, FY 2023
Figure 47 Hangzhou NovaHealth Technology Co. Ltd.: Revenue Shares, by Business Unit, FY 2022
Figure 48 Hangzhou NovaHealth Technology Co. Ltd.: Revenue Shares, by Country/Region, FY 2022
Figure 49 Laboratory Corporation of America Holdings: Revenue Shares, by Business Unit, FY 2023
Figure 50 Laboratory Corporation of America Holdings: Revenue Shares, by Country/Region, FY 2023
Figure 51 Lepu Medical Technology (Beijing) Co. Ltd.: Revenue Shares, by Business Unit, FY 2023
Figure 52 Olympus Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 53 Olympus Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 54 Quest Diagnostics Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 55 QuidelOrtho Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 56 QuidelOrtho Corp.: Revenue Shares, by Country/Region, FY 2023

Companies Mentioned

  • Danaher Corp.
  • Diacarta
  • Eiken Chemical Co. Ltd.
  • Exact Sciences Corp.
  • Freenome Holdings Inc.
  • Fujifilm Holdings Corp.
  • GI-View
  • Guardant Health
  • Hangzhou Novahealth Technology Co. Ltd.
  • Laboratory Corporation of America Holdings
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Mainz Biomed N.V.
  • Novigenix SA
  • Olympus Corp.
  • Quest Diagnostics Inc.
  • Quidelortho Corp.

Table Information

Report AttributeDetails
No. of Pages166
PublishedFebruary 2025
Forecast Period2024 - 2029
Estimated Market Value ( USD ) in 2024 $ 40 Billion
Forecasted Market Value ( USD ) by 2029 $ 46.1 Billion
Compound Annual Growth Rate2.9%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Colorectal Cancer Screening Market Report 2025 - Product Image

Colorectal Cancer Screening Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Colorectal Cancer Screening & Diagnostic Market - Global Forecast 2025-2032 - Product Image

Colorectal Cancer Screening & Diagnostic Market - Global Forecast 2025-2032

  • Report
  • 189 Pages
  • Global
From
Colorectal Cancer Screening and Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Colorectal Cancer Screening and Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Colorectal Cancer Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Colorectal Cancer Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 130 Pages
  • Global
From
Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 159 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.